Aug 10, 2023 / 03:00PM GMT
Joohwan Kim - Canaccord Genuity Group Inc. - Analyst
Welcome and thanks for attending Canaccord Genuity's 43rd Annual Growth Conference. My name is Joohwan Kim and I am an associate on Whitney Ijem's genetic medicine and rare disease team. And we're very excited to have the team from Generation Bio here. It's my great pleasure to introduce the CFO, Matt Norkunas. And Generation Bio is a biotechnology company, innovating genetic medicines for people living with rare and prevalent diseases. And so with that, I'll turn it over to the team for their presentation.
Matt Norkunas - Generation Bio Co. - CFO
Thank you. Can everybody hear me? Oh, yeah, for sure. The microphone is working. So hi, everybody. Thanks for coming. I'm Matt Norkunas. I'm here to tell you the story of Gen Bio today.
Before I dive into the slides, just a little background, we were founded six years ago. And our goal is to bring to the world non-viral DNA genetic medicines. It's a very difficult challenge. It's an idea that's been around for a long time and very little progress has been
Generation Bio Co at Canaccord Genuity Growth Conference Transcript
Aug 10, 2023
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers